APA   Click to copy
Sobhani, N., Fassl, A., Mondani, G., Generali, D., & Otto, T. (2021). Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer. Cells, 10(2), 293. https://doi.org/10.3390/cells10020293

Chicago/Turabian   Click to copy
Sobhani, Navid, Anne Fassl, Giuseppina Mondani, Daniele Generali, and Tobias Otto. “Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer.” Cells 10, no. 2 (2021): 293.

MLA   Click to copy
Sobhani, Navid, et al. “Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer.” Cells, vol. 10, no. 2, 2021, p. 293, doi:10.3390/cells10020293.

@article{navid2021a,
  title = {Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer},
  year = {2021},
  issue = {2},
  journal = {Cells},
  pages = {293},
  volume = {10},
  doi = {10.3390/cells10020293},
  author = {Sobhani, Navid and Fassl, Anne and Mondani, Giuseppina and Generali, Daniele and Otto, Tobias}
}